Author

Ami K. Patel

Mount Sinai Health SystemORCID 0000-0002-2638-4220Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:differential expression· 2 Organism:human· 2 Approach:statistical model· 2 Assay:bulk RNA-seq· 1 Research Focus:cell type annotation· 1 Research Focus:clustering· 1 Assay:scRNA-seq· 1

Frequent Co-Authors

Molly HammelliD· 2 shared David C. MolikiD· 1 shared Grinu MathewiD· 1 shared James B HicksiD· 1 shared Kathryn O’NeilliD· 1 shared Naishitha AnaparthyiD· 1 shared Toby P. AicheriD· 1 shared Wen‐Wei LiaoiD· 1 shared

Activity by Year

2018-2018 · peak 2/yr

Co-Author Collaboration Network

9 top collaborators · 24 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersGenomics

Molly HammellORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

GenomicsFrontiers in GeneticsPeer-reviewedOct 5, 2018

TEsmall identifies small RNAs associated with targeted inhibitor resistance in melanoma

Kathryn O’Neill, Wen‐Wei Liao, Ami K. Patel, Molly Hammell

TEsmall identifies small RNAs associated with targeted inhibitor resistance in melanoma by analyzing multiple small RNA classes in an integrated workflow.

8 citations

humanbulk RNA-seq

𝕏 PostBluesky

GenomicsGenome ResearchPeer-reviewedSep 1, 2018

SAKE (Single-cell RNA-Seq Analysis and Klustering Evaluation) Identifies Markers of Resistance to Targeted BRAF Inhibitors in Melanoma Cell Populations

Yu-Jui Ho, Naishitha Anaparthy, David C. Molik…·Molly Hammell

SAKE identifies markers of resistance to BRAF inhibitors in melanoma cells by analyzing scRNA-Seq data from multiple platforms.

97 citations

humanscRNA-seq

𝕏 PostBluesky